There are 3397 resources available
Multi-omic profiling in lymphoid neoplasms
Presenter: Iñaki Martin Subero
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast
Invited Discussant LBA68 and LBA69
Presenter: Daniel Shao Weng Tan
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Governmental policies to control cancer medicine prices
Presenter: Kiusiang Tay-Teo
Session: Making essential cancer drugs affordable
Resources:
Slides
Webcast
Degrading cancer targets on the cell surface (SureTACs)
Presenter: Madelon Maurice
Session: Protein degrading cancer drugs: The promises of the new generation
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 1 - Genitourinary tumours, non-prostate
Resources:
Webcast
LBA70 - OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833)
Presenter: Yoshiro Nakahara
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
Future directions neoadjuvant versus adjuvant
Presenter: Dominik Modest
Session: Fight the enemy as soon as possible: News and views in the management of early stages colorectal cancer (CRC)
Resources:
Slides
Webcast
Bifunctional small molecules that mediate the degradation of extracellular proteins
Presenter: David Spiegel
Session: Protein degrading cancer drugs: The promises of the new generation
Resources:
Slides
Webcast
Intra-tumoural immunotherapy
Presenter: Ignacio Melero
Session: Advancing strategies for cancer immunotherapy
Resources:
Slides
Webcast
Beyond chemo and endocrine therapy
Presenter: Stephen Johnston
Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer
Resources:
Slides
Webcast